Patent Assignment
Reel/Frame 023769/0122
Merger
Recorded: 2010-01-12
Pages: 119
Assignor
BAYER HEALTHCARE AG
Executed: 2008-12-04
Assignee
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
MUELLERSTRASSE 178, BERLIN, 13353, GERMANY
Covered Properties
(158)
1-Methyl-1H-Pyrazole-4-Carboxamides Useful as Cancer Chemotherapeutic Agents
PCT:
PCT/US2006/021550 ↗
Pyridonecarboxamide Derivatives Useful in Treating Hyper-Proliferative and Angiogenesis Disorders
PCT:
PCT/US2007/011981 ↗
Ciprofloxacin-Hydrocortisone Suspension
Patent:
5,965,549 →
Application:
08/801,891 →
Non-Irritation, Non-Sensitizing, Non-Ototoxic, Otic Anti-Bacterial Compositions
Patent:
5,843,930 →
Application:
08/838,473 →
Floribunda Rose Plant Named 'Jactafl'
Patent:
11,220 →
Application:
09/001,569 →
Process for the Removal of Carbonyl Compounds in Isomerization Feed Streams
Patent:
5,986,157 →
Application:
09/018,110 →
Fabrication of a Circuit Module with a Coaxial Transmission
Patent:
6,081,988 →
Application:
09/070,033 →
Network Document Transmission to Receiving Display Stations with Automatic Sizing of Received Document Caches Based Upon User Activity in Prior Browsing Sessions
Patent:
6,715,056 →
Application:
09/070,039 →
Safety Cover for Electrical Outlets
Patent:
6,159,034 →
Application:
09/088,060 →
Pressure-Controlled Continuous Coronary Sinus Occlusion Device and Methods of Use
Patent:
6,569,145 →
Application:
09/275,797 →
Dispersant Additive
Patent:
6,255,258 →
Application:
09/432,740 →
Process for Preparing Nifedipine
Patent:
6,294,673 →
Application:
09/446,478 →
Impurity Processing Apparatus and Method for Cleaning Impurity Processing Apparatus
Patent:
6,435,196 →
Application:
09/451,706 →
Plasmids, Their Construction and Their Use in the Manufacture of Interleukin-4 and Interleukin-4 Muteins
Patent:
6,506,590 →
Application:
09/483,419 →
Medicament Formulation with a Controlled Release of an Active Agent
Patent:
6,270,799 →
Application:
09/508,868 →
Substituted Tetrahydronaphthaline and Analogous Compounds
Patent:
6,586,613 →
Application:
09/508,958 →
Osmotic Medicament Releasing System
Patent:
6,294,201 →
Application:
09/530,158 →
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors
Patent:
6,362,178 →
Application:
09/554,162 →
Dihydropyrimidines
Patent:
6,696,451 →
Application:
09/673,592 →
Method for producing (s,s)-benzyl-2,8-diazabicyclo[4.3.0]nonane
Patent:
6,235,908 →
Application:
09/700,107 →
Substituted Pyrazole Derivatives
Patent:
6,833,364 →
Application:
09/744,703 →
Substituted Pyrazole Derivatives Condensed with Six-Membered Heterocyclic Rings
Patent:
6,743,798 →
Application:
09/744,830 →
Tan-1057 Derivatives
Patent:
6,617,332 →
Application:
09/763,711 →
Multiple Unit Controlled Food Effect-Independent Release Pharmaceutical Preparations and Method for Preparing the Same
Patent:
6,805,881 →
Application:
09/787,229 →
Pharmaceutical Moxifloxacin Preparation
Patent:
6,610,327 →
Application:
09/830,770 →
Human Neuropeptide Y-Like G Protein-Coupled Receptor
2-Phenyl Substituted Imidatriazinones as Phosphodiesterase Inhibitors
Patent:
6,566,360 →
Application:
09/943,530 →
Pyridine Derivatives
Patent:
6,562,811 →
Application:
09/956,618 →
Process for the Preparation of Sulphonamide-Substituted Imidazotriazinones
Aqueous Pharmaceutical Composition Containing Moxifloxacin or Salts Thereof
Patent:
6,916,484 →
Application:
10/049,094 →
Rho-kinase inhibitors
Application:
10/103,566 →
Publication:
US 2003/0125344
Substituted 2-Thio-3,5-Dicyano-4-Aryl-6-Aminopyridines and the Use Thereof
Patent:
7,135,486 →
Application:
10/110,284 →
Imidazotriazinone-Containing Compositions for Nasal Administration
4-Amino-5,6-Substituted Thiopheno [2,3-D] Pyrimidines, Pharmaceutical Compositions Containing the Same, and Their Use in the Treatment or Prevention of PDE7B-Mediated Diseases and Conditions
Substituted Oxazolidinones and Their Use in the Field of Blood Coagulation
Imidazopyrimidine Derivatives and Triazolopyrimidine Derivatives
Sustained-Release Preparations of Quinolone Antibiotics and Method for Preparation Thereof
Rho-kinase inhibitors
Application:
10/339,393 →
Publication:
US 2004/0014755
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors
Method for Producing 8-Methoxy-Quinoline Carboxylic Acids
Isolated Luciferases and the Use Thereof
Carbamate-Substituted Pyrazolopyridine Derivatives
Novel Sulfonamide-Substituted Pyrazolopyridine Derivatives
Fluorescence-Measuring System
Side-Chain Halogenated Amino Dicarboxylic Acid Derivatives as Medicaments for Treating Cardiovascular Diseases
Halogen-Substituted Amino Dicarboxylic Acid Derivatives as Medicaments for Treating Cardiovascular Diseases
Substituted 2-Oxy-3,5-Dicyano-4-Aryl-6-Aminopyridines and Use Thereof
Novel Derivatives of Dicarboxylic Acid Having Pharmaceutical Properties
Novel amino dicarboxylic acid derivatives with pharmaceutical properties
Application:
10/469,817 →
Publication:
US 2004/0082798
Substituted Oxazolidinones and Their Use in the Field of Blood Coagulation
Adenosine Receptor Selective Modulators
Substituted 2-Carba-3,5-Dicyano-4-Aryl-6-Aminopyridines and the Use of the Same as Selective Ligands of the Adenosine Receptor
Substituted 2-Thio-3,5-Dicyano-4-Phenyl-6-Aminopyridines with Adenosine Receptor-Binding Activity and Their Use Cardiovascular Preparations
Novel use of 2-phenyl-substituted imidazotriazinones
Application:
10/476,939 →
Publication:
US 2004/0152700
Novel Sulfonate Substituted Pyrazol Pyridine Derivatives
Method for Separating Methyl 4-(2-Chloro-4-Fluorophenyl)-2-(3,5-Difluoro-2-Pyridinyl)-6-Methyl-1,4-Dihydro-5-Pyrimidine-Carboxylate-Racemate
Use of 2-Alkoxyphenol-Substituted Imidazotriazinones
Substituted 2-Thio-3, 5-Dicyano-4-Phenyl-6-Aminopyridines and Their Use as Adenosine Receptor-Selective Ligands
Substituted Isoindoles and the Use Thereof
Substituted Isoindoles and the E Use Thereof
Novel 4-aminofuropyrimidines and the use thereof
Application:
10/487,373 →
Publication:
US 2004/0259888
Antibacterial Macrocycles
3-'Hydroxy-(-4-Trifluoromethylphenyl)-Methyl-7-Spirocyclobutyl-5,6,7 8-Tetrahydroquinolin-5-Ol Derivatives and the Use of the Same as Cholesterol Ester Transfer Protein (Cetp) Inhibitors
Application:
10/491,465 →
Publication:
US 2005/0043341
Process for Renaturation of Recombinant, Disulfide Containing Proteins at High Protein Concentrations in the Presence of Amines
Derivatives of Andrimide and Moiramide B Having Antibacterial Properties
Heteroaryl Carboxylic Acid Amides
Substituted 2-Thio-3,5-Dicyano-4-Phenyl-6-Aminopyridines and the Use of the Same
Bicyclic N-Arylamides
1 4-Dihydro-1 4-Diphenylpyridine Derivatives
2-Heteroarylcarboxylic Acid Amides
Stable salts of o-acetylsalicylic acid containing basic amino acids II
Application:
10/501,677 →
Publication:
US 2005/0171070
Amides of Acetic and Propionic Acids
Optically Active Pyridine Derivative and a Medicament Containing the Same
Aza-Bicyclic N-Biarylamides with Affinity for the Alpha-7 Nicotinic Acetylcholine Receptor
Diagnostics and therapeutics for diseases associated with homo sapiens formyl peptide receptor-like 2
Application:
10/508,765 →
Publication:
US 2006/0057577
Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate
Application:
10/510,908 →
Publication:
US 2006/0009420
Substituted 2-Phenyl-3(2H)-Pyridazinones
Cinnamic Acid Amides
Carbamate-Substituted Pyrazolopyridines
Derivatives of 2-(1-Benzyl-1H-Pyrazolo(3,4-B)Pyridine-3-Yl)- 5(-4-Pyridiny)L-4- Pyrimidinamines and the Use Thereof as Quanylate Cyclase Stimulators
2-Heteroaryl Carboxamides
Process for the purification of interleukin-4 and its muteins
Application:
10/520,883 →
Publication:
US 2006/0134690
Medicaments Containing Vardenafil Hydrochloride Trihydrate
Azabicyclic Carbamates and Their Use as Alpha-7 Nicotinic Acetylcholine Receptor Agonists
Arylamides
Dihydropyridinone Derivatives
Biomarkers for diagnosing alzheimer's disease
Application:
10/525,633 →
Publication:
US 2006/0240561
Dihydropyridine Derivatives for Use as Human Neutrophil Elastase Inhibitors
Fused Azole-Pyrimidine Derivatives
1-PHENY1-3,4-Dihydropyrimidin-2(1H)-One Derivatives and Their Use
Pyrimidinone Derivaties as Therapeutic Agents Against Acute and Chronic Inflammatory, Ischaemic and Remodelling Processes
Heteroaryloxy-Substituted Phenylaminopyrimidines as Rho-Kinase Inhibitors
Substituted Quinazolines as Antiviral Agents, Especially Against Cytomegaloviruses
Isolated Fluorescent Protein from Clytia Gregaria Cgfp and Use Thereof
Isophthalic Acid Derivatives
2-(3-Phenyl-2-Piperazinyl-3,4-Dihydroquinazolin-4-Yl)Acetic Acids as Antiviral Agents, Especially Against Cytomegaloviruses
Hydroxy-Tetrahydro-Naphthalenylurea Derivatives
Heterocyclyl-Substituted Dihydroquinazolines and Their Use as Antiviral Agents
Substituted Tetrahydrobenzothienopyrimidinamine Compounds Useful for Treating Hyper-Proliferative Disorders
Heterocyclic Compounds
Application:
10/557,168 →
Publication:
US 2007/0066615
N-Biarylamides
Modulators of the potassium channels twik-1, task-1 gorl1. sk2 pr pcn1, used to treat arrhythmia, coronary heat disease or hypertension
Application:
10/565,185 →
Publication:
US 2006/0183665
Determination of Free Fractions
Method for the Production of 4-(4-Aminophenyl)-3-Morpholinone
Direct observation of molecular modifications in biological test systems by measuring flourescence lifetime
Application:
10/575,026 →
Publication:
US 2007/0042500
Tetradydro-Naphthalene And Urea Derivatives
Application:
10/575,027 →
Publication:
US 2008/0045546
Selective neuropeptide y2 receptor agonists
Application:
10/576,674 →
Publication:
US 2009/0105122
Novel Combination Containing a Stimulator of Soluble Guanylate Cyclase and a Lipid-Lowering Substance
Application:
10/578,412 →
Publication:
US 2007/0225299
Tetrahydro-Quinolinylurea Derivatives
Bicyclic Amide, Carbamate or Urea Derivatives as Vanilloid Receptor Modulators
Application:
10/578,490 →
Publication:
US 2008/0058377
Substituted Dihydroquinazolines Ii
Pyrrolopyridine-Substituted Benzol Derivatives for Treating Cardiovascular Diseases
Application:
10/582,184 →
Publication:
US 2008/0249105
Tetrahydrobenzo(D)Azepin-2-One Derivatives and the Use Thereof for Treating Cardiovascular Diseases
Dihydropyridinone Derivatives
1,4-Diaryl-Dihydropyrimidin-2-Ones and Their Use as Human Neutrophil Elastase Inhibitors
Heterocyclic Derivatives
Treatment of Bacterial Diseases of the Respiratory Organs
Dihydropyrimidines
Application:
10/781,075 →
Publication:
US 2004/0167135
Imidazotriazinone-containing compositions for nasal administration
Application:
10/813,801 →
Publication:
US 2004/0248891
Novel substituted pyrazole derivatives
Application:
10/856,153 →
Publication:
US 2004/0224945
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors
Process for the Preparation of Sulphonamide-Substituted Imidazotriazinones
Method for Producing 8-Methoxy-Quinoline Carboxylic Acids
Use of 2-Alkoxyphenyl-Substituted Imidazotriazinones
Methods of Treating Medical Conditions Using Sulfonate-Substituted Pyrazolopyridine Derivatives
Medical Uses of Carbamate-Substituted Pyrazolo-Pyridine Derivatives
Novel Aminodicarboxylic Acid Derivatives Having Pharmaceutical Properties
Methods for Treating Heart Failure, Thromboembolic Disorders, and Pulmonary Fibrosis
Novel Halogen-Substituted Aminodicarboxylic Acid Derivatives
Pyridine Derivatives
Pyridine Derivatives
Pyrazinedicarboxamides and Their Use
Application:
11/299,342 →
Publication:
US 2006/0287315
Substituted 2-Thio-3,5-Dicyano-4-Aryl-6-Aminopyridines and Their Use
Substituted 2-Oxo-3-Phenyl-5-Carbonylaminomethyl-1, 3-Oxazolines and Their Use as Anticoagulant and Antithrombotics
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors, for Treatment of Hypertension
Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
Application:
11/443,693 →
Publication:
US 2006/0217373
Effervescent preparation of a basic medicinally active substance
Application:
11/454,462 →
Publication:
US 2007/0048375
Hetaryloxy-Substituted Phenylamino Pyrimidines as Rho Kinase Inhibitors
Substituted Azaquinazolines Having an Antiviral Action
Formulations With Controlled Release Of Active Ingredient
Application:
11/579,925 →
Publication:
US 2008/0187588
Substituted Aminodicarboxylic Acid Derivatives Having Pharmaceutical Properties
Substituted Phenylamino-Pyrimidines
Method for generating a hierarchical topological tree of 2D or 3D-structural formulas of chemical compounds for property optimisation of chemical compounds
Application:
11/588,894 →
Publication:
US 2007/0043511
Substituted 2, 6-Diamino-3, 5-Dicyano-4-Arylpyridines and Their Use as Adenosine-Receptor-Selective Ligands
2-Aminoarylcarboxamides Useful as Cancer Chemotherapeutic Agents
Application:
11/630,850 →
Publication:
US 2008/0293696
3,5-Difluoropyridines
Regulation of novel human asparagine-hydroxylases
Application:
11/642,503 →
Publication:
US 2007/0117142
Pyrimidinothienoindazoles Useful for the Treatment of Hyperproliferative Disorders
Method For Treating Bronchoconstriction and Pulmonary Vaso-Constriction
Application:
11/664,882 →
Publication:
US 2008/0138444
Novel Heterocycles
Novel Pyrimidothienoindazoles
Substituted Isoindoles and Their Use
Substituted [(Phenylethanoyl)Amino]Benzamides
Helical Gear Supporting Structure, Speed Increaser for Wind Power Generator, and Vertical Shaft Supporting Structure
Application:
11/795,752 →
Publication:
US 2008/0118344
Pharmaceutical Forms with Improved Pharmacokinetic Properties
Heteroaryl Carboxamides
Use of 2-alkoxyphenyl-substituted imidazotriazinones
Application:
11/906,382 →
Publication:
US 2008/0085897
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Nunc Pro Tunc Assignment
Dec 4, 2009
From: BAYER PHARMACEUTICALS CORPORATION
To: BAYER HEALTHCARE AG
Reel/Frame 023605/0562 →
Nunc Pro Tunc Assignment
Jan 27, 2010
From: BAYER CORPORATION
To: BAYER PHARMACEUTICALS CORPORATION
Reel/Frame 023854/0934 →
Change of Name
Apr 23, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 028093/0091 →
Confirmatory Assignment
Apr 23, 2012
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 028093/0393 →
Assignment of Assignor's Interest
Feb 8, 2013
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 029780/0432 →
Change of Name
Feb 8, 2013
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 029780/0632 →
Assignment of Assignor's Interest
Oct 9, 2013
From: BAYER AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 031369/0175 →
Assignment of Assignor's Interest
Dec 23, 2014
From: BAYER INTELLECTUAL PROPERTY GMBH
To: ADVERIO PHARMA GMBH
Reel/Frame 034577/0443 →
Corrective Assignment to Correct the Application Number 14217644 Previously Recorded at Reel: 034577 Frame: 0443. Assignor(S) Hereby Confirms the Assignment.
Jan 21, 2015
From: BAYER INTELLECTUAL PROPERTY GMBH
To: ADVERIO PHARMA GMBH
Reel/Frame 034839/0604 →
Change of Name
Oct 6, 2017
From: GOOGLE INC.
To: GOOGLE LLC
Reel/Frame 044144/0001 →
Correction by Affidavit to Correct Erroneously Patent Number 598157 on Reel 00891 Frame 0797.
Nov 30, 2017
From: CATALYTIC DISTILLATION TECHNOLOGIES
To: CATALYTIC DISTILLATION TECHNOLOGIES
Reel/Frame 044782/0713 →
Corrective Assignment to Correct the the Removal of the Incorrectly Recorded Application Numbers 14/149802 and 15/419313 Previously Recorded at Reel: 44144 Frame: 1. Assignor(S) Hereby Confirms the Change of Name.
Mar 4, 2024
From: GOOGLE INC.
To: GOOGLE LLC
Reel/Frame 068092/0502 →